Catalyst Wire Dossier Catalyst Wire Dossier

Mogamulizumab

mogamulizumab · Kyowa Kirin
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Mogamulizumab, covering 2017-03-03 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma [Phase 2]

See pricing